Preoperative MRI of the Breast (POMB) Influences Primary Treatment in Breast Cancer: A Prospective, Randomized, Multicenter Study

被引:86
|
作者
Gonzalez, Virginia [1 ]
Sandelin, Kerstin [2 ]
Karlsson, Anders [3 ]
Aberg, Wiveca [2 ]
Lofgren, Lars [4 ]
Iliescu, Gabriela [5 ]
Eriksson, Staffan [1 ]
Arver, Brita [6 ]
机构
[1] Vastmanland Cty Hosp, Dept Surg, S-72189 Vasteras, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden
[3] Capio St Gorans Hosp, Dept Radiol, S-11281 Stockholm, Sweden
[4] Capio St Gorans Hosp, Dept Surg, S-11281 Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Radiol, S-17176 Stockholm, Sweden
[6] Karolinska Inst, Dept Oncol & Pathol, S-17176 Stockholm, Sweden
关键词
SENTINEL NODE BIOPSY; SURGICAL-MANAGEMENT; CARCINOMA; ACCURACY;
D O I
10.1007/s00268-014-2605-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Breast magnetic resonance imaging (MRI) has shown high sensitivity in determining tumor extent, multifocality, and occult contralateral breast cancer. Low specificity, unnecessary mastectomies, and costs are arguments against MRI. The purpose of this study was to determine whether preoperative breast MRI would affect primary surgical management, reduce reexcision/reoperation procedures, and influence the choice of neoadjuvant treatment in patients with newly diagnosed breast cancer. This prospective, randomized, multicenter study included 440 breast cancer patients younger than aged 56 years from three, Swedish, large-volume breast units. Patients were randomly allocated on a 1:1 basis to either preoperative staging with breast MRI (n = 220) or no breast MRI (n = 220) (control group). Treatment planning of all patients was discussed at multidisciplinary team conferences. In patients randomized to the MRI group, who had an observed higher percentage of planned breast-conserving surgery (BCS) compared with the control group, a change from suggested breast conservation to mastectomy occurred in 23 of 153 (15 %) patients. Breast MRI provided additional information in 83 of 220 (38 %) patients, which caused a change in treatment plan in 40 (18 %). The breast reoperation rate was significantly lower in the MRI group: 11 of 220 (5 %) versus 33 of 220 (15 %) in the control group (p < 0.001). The number of mastectomies, axillary reoperations, and the number of patients receiving neoadjuvant chemotherapy after definitive treatment did not differ significantly between the groups. Preoperative staging with breast MRI in women younger than age 56 years altered the treatment plan in 18 % of the patients. Although a higher MRI-related conversion rate from breast conservation to mastectomy was found, the final numbers of mastectomies did not differ between the two groups. The breast reoperation rate in the MRI group was significantly reduced.
引用
收藏
页码:1685 / 1693
页数:9
相关论文
共 50 条
  • [1] Preoperative MRI of the Breast (POMB) Influences Primary Treatment in Breast Cancer: A Prospective, Randomized, Multicenter Study
    Brenner, R. J.
    Breast Diseases, 2015, 26 (01): : 36 - 38
  • [2] Preoperative MRI of the Breast (POMB) Influences Primary Treatment in Breast Cancer: A Prospective, Randomized, Multicenter Study
    Virginia Gonzalez
    Kerstin Sandelin
    Anders Karlsson
    Wiveca Åberg
    Lars Löfgren
    Gabriela Iliescu
    Staffan Eriksson
    Brita Arver
    World Journal of Surgery, 2014, 38 : 1685 - 1693
  • [3] Group therapy for primary breast cancer patients: A randomized prospective multicenter trial
    Spiegel, D
    Classen, C
    Koopman, C
    Atkinson, A
    DiMiceli, S
    Stonisch-Riggs, G
    Westendorp, J
    Morrow, G
    PSYCHO-ONCOLOGY, 1999, 8 (06) : 7 - 7
  • [4] The Influence of Preoperative MRI on Breast Cancer Treatment
    Miller, Benjamin T.
    Abbott, Andrea M.
    Tuttle, Todd M.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) : 536 - 540
  • [5] The Influence of Preoperative MRI on Breast Cancer Treatment
    Benjamin T. Miller
    Andrea M. Abbott
    Todd M. Tuttle
    Annals of Surgical Oncology, 2012, 19 : 536 - 540
  • [6] Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
    Eiermann, W
    Paepke, S
    Appfelstaedt, J
    Llombart-Cussac, A
    Eremin, J
    Vinholes, J
    Mauriac, L
    Ellis, M
    Lassus, M
    Chaudri-Ross, HA
    Dugan, M
    Borgs, M
    Semiglazov, V
    ANNALS OF ONCOLOGY, 2001, 12 (11) : 1527 - 1532
  • [7] Treatment strategies in male breast cancer: Results of a prospective multicenter study
    Eggemann, Holm
    Brucker, Cosima
    Schirrmeister, Susen
    Ringsdorf, Uta
    Augustin, Doris
    Schrauder, Michael
    Thill, Marc
    Flock, Felix
    Kraudelt, Susanne
    Gad, Gabriele
    Kleine-Tebbe, Anke
    Reinisch, Mattea
    Costa, Serban-Dan
    Ignatov, Atanas
    CANCER RESEARCH, 2020, 80 (04)
  • [8] Impact of preoperative breast MRI on 10-year survival of patients included in the Swedish randomized multicentre POMB trial
    Gonzalez, V.
    Arver, B.
    Lofgren, L.
    Bergkvist, L.
    Sandelin, K.
    Eriksson, S.
    BJS OPEN, 2021, 5 (05):
  • [9] A prospective randomized multicenter gene expression study of docetaxel vs doxorubicin/cyclophosphamide preoperative trial in primary breast cancers.
    Makris, A
    Hisenbeck, SG
    Yee, D
    Osborne, KC
    Elledge, RM
    Harrison, M
    Ostler, PJ
    Mohsin, S
    Gutierrez, CM
    Chang, JC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 14S - 14S
  • [10] The accuracy of incremental pre-operative breast MRI findings - Concordance with histopathology in the Swedish randomized multicenter POMB trial
    Karlsson, Anders
    Gonzalez, Virginia
    Jaraj, Sara Jonmarker
    Bottai, Matteo
    Sandelin, Kerstin
    Arver, Brita
    Eriksson, Staffan
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 114 : 185 - 191